INDIGO News

INDIGO Now Offers Nrf2 Assay Systems

New Assay Critical to the study of toxic chemicals in the body and brain degenerative disorders State College, PA (March 19, 2015) – INDIGO Biosciences, a recognized industry-leading provider of nuclear receptor products and services, announced today that it has completed development of Human Nuclear Factor (erythroid-derived 2)-like 2 (Nrf2). Kits and services are availableRead More

NRR - Nuclear Receptor Resource

Our Newest Kits

Nrf2 (Human)

Our Newest Services

Our Newest Services
PXR